BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li SF, Zhao FR, Shao JJ, Xie YL, Chang HY, Zhang YG. Interferon-omega: Current status in clinical applications. Int Immunopharmacol 2017;52:253-60. [PMID: 28957693 DOI: 10.1016/j.intimp.2017.08.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Cao L, Zhang L, Zhang X, Liu J, Jia MA, Zhang J, Liu J, Wang F. Types of Interferons and Their Expression in Plant Systems. J Interferon Cytokine Res 2022;42:62-71. [PMID: 35171703 DOI: 10.1089/jir.2021.0148] [Reference Citation Analysis]
2 Wang X, Li F, Han M, Jia S, Wang L, Qiao X, Jiang Y, Cui W, Tang L, Li Y, Xu YG. Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins. Viruses 2020;12:E335. [PMID: 32204464 DOI: 10.3390/v12030335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Setthawongsin C, Tangkawattana S, Rungsipipat A, Techangamsuwan S. In vitro Effect of Recombinant Feline Interferon-Ω (rFeIFN-Ω) on the Primary CanineTransmissible Venereal Tumor Culture. Front Vet Sci 2019;6:104. [PMID: 31024941 DOI: 10.3389/fvets.2019.00104] [Reference Citation Analysis]
4 Zhang T, Liu Y, Chen Y, Wang J, Feng H, Wei Q, Zhao S, Yang S, Ma H, Liu D, Zhang G. Antiviral activity of porcine interferon delta 8 against pesudorabies virus in vitro. Int J Biol Macromol 2021;177:10-8. [PMID: 33548323 DOI: 10.1016/j.ijbiomac.2021.01.208] [Reference Citation Analysis]
5 Capozza P, Pratelli A, Camero M, Lanave G, Greco G, Pellegrini F, Tempesta M. Feline Coronavirus and Alpha-Herpesvirus Infections: Innate Immune Response and Immune Escape Mechanisms. Animals (Basel) 2021;11:3548. [PMID: 34944324 DOI: 10.3390/ani11123548] [Reference Citation Analysis]
6 Mueller RS, Hartmann K. Interferon therapies in small animals. Vet J 2021;271:105648. [PMID: 33840487 DOI: 10.1016/j.tvjl.2021.105648] [Reference Citation Analysis]
7 Anderson JG, Hennet P. Management of Severe Oral Inflammatory Conditions in Dogs and Cats. Vet Clin North Am Small Anim Pract 2022;52:159-84. [PMID: 34838249 DOI: 10.1016/j.cvsm.2021.09.008] [Reference Citation Analysis]
8 Li SF, Zhao FR, Gong MJ, Shao JJ, Xie YL, Chang HY, Zhang YG. Antiviral activity of porcine interferon omega 7 against foot-and-mouth disease virus in vitro. J Med Virol 2019;91:208-14. [PMID: 30039874 DOI: 10.1002/jmv.25272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Frazzini S, Riva F, Amadori M. Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future. Vet Sci 2021;8:109. [PMID: 34208413 DOI: 10.3390/vetsci8060109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gomez-Lucia E, Collado VM, Miró G, Martín S, Benítez L, Doménech A. Clinical and Hematological Follow-Up of Long-Term Oral Therapy with Type-I Interferon in Cats Naturally Infected with Feline Leukemia Virus or Feline Immunodeficiency Virus. Animals (Basel) 2020;10:E1464. [PMID: 32825496 DOI: 10.3390/ani10091464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ma Y, Su XZ, Lu F. The Roles of Type I Interferon in Co-infections With Parasites and Viruses, Bacteria, or Other Parasites. Front Immunol 2020;11:1805. [PMID: 33193291 DOI: 10.3389/fimmu.2020.01805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ramos TI, Villacis-Aguirre CA, Santiago Vispo N, Santiago Padilla L, Pedroso Santana S, Parra NC, Alonso JRT. Forms and Methods for Interferon's Encapsulation. Pharmaceutics 2021;13:1533. [PMID: 34683824 DOI: 10.3390/pharmaceutics13101533] [Reference Citation Analysis]
13 Pavlovich SS, Darling T, Hume AJ, Davey RA, Feng F, Mühlberger E, Kepler TB. Egyptian Rousette IFN-ω Subtypes Elicit Distinct Antiviral Effects and Transcriptional Responses in Conspecific Cells. Front Immunol 2020;11:435. [PMID: 32231668 DOI: 10.3389/fimmu.2020.00435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wittling MC, Cahalan SR, Levenson EA, Rabin RL. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes. Front Immunol 2020;11:605673. [PMID: 33542718 DOI: 10.3389/fimmu.2020.605673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Andreeva A, Nikolaeva O, Altynbekov O, Galieva C, Ilina K. Influence of interferon-based drugs on immunological indices in specific prevention. Vet World 2020;13:238-44. [PMID: 32255964 DOI: 10.14202/vetworld.2020.238-244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Decker T. The early interferon catches the SARS-CoV-2. J Exp Med 2021;218:e20211667. [PMID: 34424267 DOI: 10.1084/jem.20211667] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Abdolvahab MH, Darvishi B, Zarei M, Majidzadeh-A K, Farahmand L. Interferons: role in cancer therapy. Immunotherapy 2020;12:833-55. [PMID: 32635782 DOI: 10.2217/imt-2019-0217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]